annual SGA:
$0.00-$249.75M(-100.00%)Summary
- As of today (September 13, 2025), RPRX annual SGA is $0.00, with the most recent change of -$249.75 million (-100.00%) on December 31, 2024.
- During the last 3 years, RPRX annual SGA has fallen by -$182.83 million (-100.00%).
- RPRX annual SGA is now -100.00% below its all-time high of $249.75 million, reached on December 31, 2023.
Performance
RPRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$179.77M+$69.06M(+62.39%)Summary
- As of today (September 13, 2025), RPRX quarterly SGA is $179.77 million, with the most recent change of +$69.06 million (+62.39%) on June 30, 2025.
- Over the past year, RPRX quarterly SGA has increased by +$125.06 million (+228.60%).
- RPRX quarterly SGA is now at all-time high.
Performance
RPRX quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
$10.31B-$155.50M(-1.49%)Summary
- As of today (September 13, 2025), RPRX TTM SGA is $10.31 billion, with the most recent change of -$155.50 million (-1.49%) on June 30, 2025.
- Over the past year, RPRX TTM SGA has increased by +$10.08 billion (+4408.17%).
- RPRX TTM SGA is now -1.49% below its all-time high of $10.47 billion.
Performance
RPRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
RPRX Selling, general & administrative expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -100.0% | +228.6% | +4408.2% |
3 y3 years | -100.0% | +246.8% | +5105.5% |
5 y5 years | -100.0% | +320.0% | +7862.6% |
RPRX Selling, general & administrative expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -100.0% | at low | at high | +277.4% | -1.5% | +20.4% |
5 y | 5-year | -100.0% | at low | at high | +320.0% | -1.5% | +48.2% |
alltime | all time | -100.0% | at low | at high | +679.5% | -1.5% | +265.1% |
RPRX Selling, general & administrative expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $179.77M(+62.4%) | $414.79M(+43.2%) |
Mar 2025 | - | $110.70M(+63.8%) | $289.72M(+22.4%) |
Dec 2024 | $0.00(-100.0%) | $67.59M(+19.2%) | $236.67M(+3.7%) |
Sep 2024 | - | $56.72M(+3.7%) | $228.26M(-0.2%) |
Jun 2024 | - | $54.71M(-5.1%) | $228.78M(+3.2%) |
Mar 2024 | - | $57.65M(-2.6%) | $221.71M(-11.2%) |
Dec 2023 | $249.75M(+9.9%) | $59.19M(+3.4%) | $249.75M(-5.3%) |
Sep 2023 | - | $57.23M(+20.2%) | $263.79M(+2.5%) |
Jun 2023 | - | $47.63M(-44.4%) | $257.25M(-1.6%) |
Mar 2023 | - | $85.69M(+17.0%) | $261.46M(+15.0%) |
Dec 2022 | $227.30M(+24.3%) | $73.23M(+44.5%) | $227.30M(+13.5%) |
Sep 2022 | - | $50.69M(-2.2%) | $200.24M(+1.1%) |
Jun 2022 | - | $51.84M(+0.6%) | $198.13M(+3.6%) |
Mar 2022 | - | $51.54M(+11.7%) | $191.21M(+4.6%) |
Dec 2021 | $182.83M | $46.16M(-5.0%) | $182.83M(-2.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | $48.59M(+8.2%) | $186.78M(-1.1%) |
Jun 2021 | - | $44.92M(+4.1%) | $188.93M(+1.1%) |
Mar 2021 | - | $43.16M(-13.9%) | $186.81M(+2.8%) |
Dec 2020 | $181.72M(+75.7%) | $50.12M(-1.2%) | $181.72M(+17.5%) |
Sep 2020 | - | $50.73M(+18.5%) | $154.66M(+19.4%) |
Jun 2020 | - | $42.80M(+12.4%) | $129.53M(+10.6%) |
Mar 2020 | - | $38.06M(+65.1%) | $117.08M(+13.2%) |
Dec 2019 | $103.44M(+67.1%) | $23.06M(-9.9%) | $103.44M(+28.7%) |
Sep 2019 | - | $25.60M(-15.6%) | $80.38M(+46.7%) |
Jun 2019 | - | $30.35M(+24.2%) | $54.77M(+124.2%) |
Mar 2019 | - | $24.43M | $24.43M |
Dec 2018 | $61.91M(-41.8%) | - | - |
Dec 2017 | $106.44M(+53.1%) | - | - |
Dec 2016 | $69.51M(-42.7%) | - | - |
Dec 2015 | $121.42M | - | - |
FAQ
- What is Royalty Pharma plc annual SGA?
- What is the all time high annual SGA for Royalty Pharma plc?
- What is Royalty Pharma plc annual SGA year-on-year change?
- What is Royalty Pharma plc quarterly SGA?
- What is the all time high quarterly SGA for Royalty Pharma plc?
- What is Royalty Pharma plc quarterly SGA year-on-year change?
- What is Royalty Pharma plc TTM SGA?
- What is the all time high TTM SGA for Royalty Pharma plc?
- What is Royalty Pharma plc TTM SGA year-on-year change?
What is Royalty Pharma plc annual SGA?
The current annual SGA of RPRX is $0.00
What is the all time high annual SGA for Royalty Pharma plc?
Royalty Pharma plc all-time high annual SGA is $249.75M
What is Royalty Pharma plc annual SGA year-on-year change?
Over the past year, RPRX annual SGA has changed by -$249.75M (-100.00%)
What is Royalty Pharma plc quarterly SGA?
The current quarterly SGA of RPRX is $179.77M
What is the all time high quarterly SGA for Royalty Pharma plc?
Royalty Pharma plc all-time high quarterly SGA is $179.77M
What is Royalty Pharma plc quarterly SGA year-on-year change?
Over the past year, RPRX quarterly SGA has changed by +$125.06M (+228.60%)
What is Royalty Pharma plc TTM SGA?
The current TTM SGA of RPRX is $10.31B
What is the all time high TTM SGA for Royalty Pharma plc?
Royalty Pharma plc all-time high TTM SGA is $10.47B
What is Royalty Pharma plc TTM SGA year-on-year change?
Over the past year, RPRX TTM SGA has changed by +$10.08B (+4408.17%)